Medical Weight Loss · Tustin & Santa Ana, CA
Dual-Action · Next Generation

Advanced dual-action weight loss therapy

Tirzepatide is the next generation of GLP-1 weight loss — targeting two metabolic pathways simultaneously for greater weight loss potential. Our compounded Tirzepatide + BPC-157 formulation adds a regenerative peptide for enhanced tolerability and wellness support.

Schedule a Consultation How It Works
Once-weekly injection
GLP-1 + GIP dual-action
+ BPC-157 peptide
Physician-supervised
About Tirzepatide

The next generation
of medical weight loss

Tirzepatide represents a significant advancement in medical weight loss. Unlike single-pathway therapies, Tirzepatide is a dual-action medication that activates both GLP-1 and GIP receptors — simultaneously addressing appetite, satiety, insulin response, and fat metabolism.

This dual-pathway approach may lead to greater weight loss and enhanced blood sugar regulation compared to single-pathway therapies — making Tirzepatide a strong option for patients seeking more robust metabolic support.

At Prestige Medical Group, our Tirzepatide is compounded with BPC-157 peptide for enhanced tolerability and wellness support — addressing the GI side effects commonly associated with GLP-1 and GLP-1/GIP medications.

Pricing: View pricing and book directly through the Prestige App.
Tirzepatide medical weight loss at Prestige Medical Group, Tustin CA
The Dual-Action Difference

Two receptors,
one synergistic therapy

Where Semaglutide activates one pathway, Tirzepatide activates two — combining the proven benefits of GLP-1 with the additional metabolic effects of GIP for results no single-pathway therapy can match.

Pathway 1
GLP-1 Receptor
Glucagon-Like Peptide-1

Reduces appetite, slows gastric emptying, and increases feelings of fullness. The same proven mechanism that drives Semaglutide’s weight loss effect.

Pathway 2
GIP Receptor
Glucose-Dependent Insulinotropic Polypeptide

Enhances insulin response, supports fat metabolism, and may improve insulin sensitivity in ways GLP-1 alone cannot — adding a second dimension to weight loss.

= Dual-Action Tirzepatide
Greater weight loss potential

The dual-pathway approach may produce greater weight loss and better insulin sensitivity than single-pathway therapies — making Tirzepatide especially valuable for patients seeking more robust metabolic support.

Four Mechanisms in One Injection

How Tirzepatide works

Tirzepatide’s dual receptor activation drives four connected mechanisms — all delivered in a single once-weekly injection.

Reduces Appetite

Activates appetite centers in the brain to reduce hunger and food cravings naturally.

Slows Gastric Emptying

Slows the rate food leaves your stomach — keeping you feeling full for longer after meals.

Enhances Insulin Response

Improves both insulin sensitivity and insulin secretion — supporting better blood sugar regulation.

Supports Fat Metabolism

GIP receptor activation supports fat metabolism — adding a metabolic dimension single-pathway therapies lack.

Our Enhanced Formulation

Compounded with BPC-157 peptide

BPC-157 (Body Protective Compound 157) is a regenerative peptide added to all our weight loss injectable treatments. It addresses the most common challenge GLP-1 and GLP-1/GIP patients face: gastrointestinal side effects.

Because Tirzepatide slows gastric emptying, some patients experience nausea, discomfort, or digestive issues — especially during dose escalation. BPC-157 supports gut health and reduces inflammation, helping you tolerate treatment more comfortably and stay on track with your weight loss goals.

Supports gut health
Reduces inflammation
Promotes tissue healing
Eases GI side effects
Benefits of Tirzepatide

Why patients choose Tirzepatide

Tirzepatide’s dual-action mechanism delivers benefits across weight, metabolism, and overall health.

Greater Weight Loss
Clinical evidence suggests Tirzepatide’s dual-action mechanism may produce greater weight loss than single-pathway GLP-1 medications.
Better Insulin Sensitivity
GIP receptor activation enhances insulin response — particularly valuable for patients with insulin resistance.
Robust Metabolic Support
Dual-pathway therapy delivers more comprehensive metabolic improvements than single-pathway approaches.
Less Food Noise
Patients commonly report less obsessive food thoughts and constant cravings — freeing mental energy for life.
Once-Weekly Convenience
A single subcutaneous injection per week — no daily pills, no complicated routines. Easy to integrate into busy life.
Physician Supervision
Every plan is personalized to your health profile, with regular check-ins to adjust dosing and monitor progress.
Am I a Candidate?

Who benefits from Tirzepatide?

Tirzepatide may be suitable for individuals seeking more robust metabolic support than single-pathway GLP-1 therapy provides. You may be a good candidate if any of the following apply:

You’ve struggled to lose weight through diet and exercise alone
You have a BMI in a qualifying range
You have weight-related health concerns
You have insulin resistance or blood sugar concerns
You want more robust results than single-pathway therapies offer
You prefer once-weekly dosing over daily medication
You’re ready to combine medication with lifestyle changes
You’re in good general health
Treatment at a Glance
Drug ClassDual GLP-1 + GIP agonist
Active IngredientTirzepatide + BPC-157
Also Known AsMounjaro, Zepbound
AdministrationSubcutaneous injection
FrequencyOnce weekly
Self-AdministeredYes, after instruction
DosingGradually titrated up
SupervisionPhysician-led
Progress TrackingInBody body composition
PricingVia Prestige App
Considering Other Options?

Also consider Semaglutide

For patients new to GLP-1 therapy or seeking a more established treatment with a longer track record, Semaglutide is our single-pathway GLP-1 option — also compounded with BPC-157. Currently available with a $99 first month special including office visit, InBody scan, and B12 injection. Your provider will recommend the best fit for your specific health profile and goals.

Common Questions

Tirzepatide questions answered

Have a question not answered here? Call us at (949) 825-7650.

Get Started
Schedule Your Consultation
Comprehensive health assessment and personalized treatment plan. Tustin & Santa Ana, CA.
Schedule Now
What is Tirzepatide? +
Tirzepatide is an advanced dual-action medication that targets both GLP-1 and GIP receptors — supporting appetite control and improved insulin sensitivity. This dual-pathway approach may lead to greater weight loss and enhanced blood sugar regulation compared to single-pathway therapies, making it a strong option for patients seeking more robust metabolic support. At Prestige Medical Group, Tirzepatide is compounded with BPC-157 peptide for enhanced tolerability.
How does Tirzepatide work? +
Tirzepatide is a dual GLP-1 and GIP receptor agonist. It activates both the GLP-1 pathway (which reduces appetite, slows gastric emptying, and increases feelings of fullness) and the GIP pathway (which enhances insulin response and supports fat metabolism). This dual-action approach affects metabolism in ways single-pathway therapies cannot — often producing greater weight loss and metabolic improvements.
What makes Tirzepatide different from Semaglutide? +
Semaglutide targets one receptor (GLP-1), while Tirzepatide targets two (GLP-1 and GIP). The dual-action approach of Tirzepatide may produce greater weight loss results and better insulin sensitivity. Both are compounded with BPC-157 at Prestige Medical Group. Your provider will recommend which is best for you based on your specific health profile, goals, and tolerance.
What is BPC-157 and why is it added? +
BPC-157 (Body Protective Compound 157) is a regenerative peptide added to all our weight loss injectable treatments. It supports gut health, reduces inflammation, and promotes tissue healing — addressing the GI side effects most commonly associated with GLP-1 and GLP-1/GIP medications. Because Tirzepatide slows gastric emptying, BPC-157 helps maintain healthy digestion throughout treatment.
How is Tirzepatide administered? +
Tirzepatide is given as a once-weekly subcutaneous injection. After initial instruction from your provider, most patients self-administer at home. Dosing begins low and is gradually titrated upward based on your individual tolerance and response.
What are the benefits of Tirzepatide? +
Tirzepatide’s dual-action mechanism may produce greater weight loss than single-pathway GLP-1 medications. Additional benefits include improved blood sugar regulation, enhanced insulin sensitivity, reduced food noise, better metabolic health, and improvements in obesity-related health markers. Many patients also report feeling more energetic and emotionally balanced.
Is Tirzepatide the same as Mounjaro and Zepbound? +
Tirzepatide is the active ingredient in both Mounjaro (FDA-approved for type 2 diabetes) and Zepbound (FDA-approved for chronic weight management). Our medical weight loss program uses Tirzepatide formulated for weight loss under physician supervision, with the addition of BPC-157 peptide for enhanced tolerability.
Who is a candidate for Tirzepatide? +
Tirzepatide may be suitable for individuals who have struggled to lose weight through diet and exercise alone — especially those seeking more robust metabolic support than single-pathway GLP-1 therapy provides. Common candidates include those with obesity, weight-related health concerns, or insulin resistance. A comprehensive health assessment will determine if Tirzepatide is right for you.
Are there side effects? +
Like all medications, Tirzepatide may have side effects. The most common are gastrointestinal — nausea, diarrhea, constipation, and mild stomach discomfort — typically more pronounced during dose escalation and tending to lessen with time. The addition of BPC-157 in our compounded formulation helps reduce these side effects. Your provider will discuss all potential side effects and monitor you during treatment.
Related Treatments
Semaglutide
Single-pathway GLP-1 weight loss — also compounded with BPC-157. Currently $99 first month special.
Learn more →
InBody Body Composition
Advanced body composition analysis that tracks fat, muscle, water, and metabolic rate
Learn more →
All Weight Loss Treatments
Browse our complete weight loss program, including all available medications and tools
View all →
BioTE® Hormone Therapy
Hormone imbalance often contributes to weight gain — BioTE can complement medical weight loss
Learn more →
Advanced Peptide Therapy
Targeted peptides for energy, recovery, and longevity — supports comprehensive wellness alongside weight loss
Learn more →
Space Touch Capsule
Full-body LED light therapy — supports overall wellness, recovery, and skin rejuvenation
Learn more →

The next generation of weight loss.

Schedule your consultation to see if Tirzepatide + BPC-157 is right for your weight loss journey. Our team will discuss your goals, assess your health, and develop a personalized plan.

Request a Consultation (949) 825-7650